Global risk of cholera continues to be ‘very high’: WHO
HQ Team June 2, 2023: Shortage of oral vaccines and overstretched public health and medical professionals are contributing to the spread of cholera,.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team June 2, 2023: Shortage of oral vaccines and overstretched public health and medical professionals are contributing to the spread of cholera,.
HQ Team June 1, 2023: Pfizer’s last-stage experimental trials for treating multi-drug-resistant bacteria have yielded positive results, the US-based company announced. The Phase.
HQ Team June 1, 2023: The World Health Organization has posted a repository of more than 450 psychoactive drugs listing their abuses, harms,.
HQ Team June 1, 2023: Seven newborns have died in France due to severe neonatal sepsis associated with enterovirus during the more than.
Europe’s largest nuclear plant, the Zaporizhzhya Nuclear Power Plant, in Ukraine, remains “extremely fragile and dangerous” because the war with Russia may escalate,.
Pfizer’s hemophilia trial cure shows a 92% cut in bleeds HQ Team May 30, 2023: Pfizer Inc.’s phase III experimental therapy for treating.
HQ Team May 30, 2023: Hunger is set to increase in severity and magnitude in 18 global hotspots out of 22 designated nations,.
"Social interactions create a sense of community, reciprocity, and trustworthiness, which are factors positively related to mental well-being and protective against depression."
Neuralink hopes to use its microchips to treat conditions such as paralysis and blindness, and to help certain disabled people use computers and.
INPEFA is an inhibitor of both sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1). This class of SGLT inhibitors was recommended as.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com